Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

November 2, 2013

Patient Stories about their use with Tecfidera

  • An MS Patients Story
    /
  • Oral MS Medications
    /
November 1, 2013 Stu, I started Tecfidera on May 18, 2013.  I was a little nervous, but was excited to…
An MS Patients Story

November 2, 2013

The New Healthcare Changes and You – Join us for a webinar on Nov. 20

  • MS Educational Programs
    /
You still have time to participate in the free 2013 National Disability Institute Financial Wellness Webinar Series for people living…
MS Educational Programs

November 1, 2013

Transcranial Magnetic Stimulation (TMS) May Reduce Depression, Fatigue in MS Patients

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
COPENHAGEN, Denmark — Deep repetitive transcranial magnetic stimulation (TMS) of the motor cortex has the potential to reduce fatigue and…
Alternative therapies and devices for Multiple Sclerosis (MS)

November 1, 2013

Antibody Index Test May Aid PML Diagnosis on Natalizumab

  • Multiple Sclerosis
    /
  • Tysabri
    /
Sue Hughes October 30, 2013 COPENHAGEN, Denmark — A new test that compares JC virus (JCV) antibody levels in cerebrospinal fluid (CSF)…
Multiple Sclerosis

October 31, 2013

New TECFIDERA Data Show Sustained Efficacy and Long-Term Safety in MS Patients

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Oral MS Medications
    /
New TECFIDERA® (Dimethyl Fumarate) Data Show Sustained Efficacy and Long-Term Safety in a Broad Range of Multiple Sclerosis Patients Interim…
MS Drug Therapies

October 31, 2013

Genmab Announces Positive Top-Line Phase II Results of Ofatumumab in MS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
October 10, 2013 Genmab Announces Positive Top-Line Phase II Results of Ofatumumab in Multiple Sclerosis Treatment with ofatumumab showed significant…
MS Drug Therapies

October 31, 2013

Study Investigates Possible Environment Trigger for MS

  • MS Research Study and Reports
    /
A bacterium that may trigger multiple sclerosis has been identified by a research team from Weill Cornell Medical College and…
MS Research Study and Reports

October 31, 2013

Researchers from Italy Report that Skin Tissue May Hold Promise for Treating Multiple Sclerosis

  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
  • Stem Cell Related
    /
NEW YORK, Oct. 29, 2013 /PRNewswire-USNewswire/ — Researchers in Milan, Italy reported that stem cells derived from mouse skin tissue were able to reduce…
Multiple Sclerosis

October 30, 2013

High Vitamin D Levels Associated with Low MS Disease Activity –

  • Multiple Sclerosis
    /
  • Vitamins and Supplements
    /
By By Jackie Syrop | October 21, 2013 Higher levels of 25-hydroxyvitamin D are correlated with less multiple sclerosis (MS) disease…
Multiple Sclerosis

October 27, 2013

Emerging MS Treatment Therapies, Symptom Management and Energy Conserving Energy for the Holidays – a Free MS education program in Atlanta, Ga

  • MS Educational Programs
    /
  • Multiple Sclerosis (MS) Symptoms
    /
  • Myelin Repair
    /
RESERVATION REQUIRED to attend this event. See details shown below: Presented By: Ben W. Thrower M.D. Medical Director, Andrew C.…
MS Educational Programs

Categories

Latest Blog Posts